Resveratrol induces apoptosis and alters gene expression in human fibrosarcoma cells

Kamran Harati1, Pawel Slodnik2, Ansgar Michael Chromik3

  • 1Department of Plastic Surgery, Burn Center, Hand Center, Sarcoma Reference Center, BG University Hospital Bergmannsheil Bochum, Bochum, Germany kamran.harati@t-online.de.

Anticancer Research
|February 11, 2015
PubMed
Abstract

Insights

Resveratrol, a natural compound, effectively induces cancer cell death and reduces proliferation in human fibrosarcoma cells. This study supports further research into resveratrol as a potential fibrosarcoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Product Chemistry

Background:

  • Metastatic fibrosarcomas present a significant therapeutic challenge.
  • Conventional chemotherapy, like doxorubicin, shows limited efficacy (<30%) and is unsuitable for certain patient groups (e.g., elderly with cardiac issues).

Purpose of the Study:

  • To investigate the apoptotic effects of resveratrol, a natural and well-tolerated compound, on human fibrosarcoma cells (HT1080).

Main Methods:

  • Quantification of vital, apoptotic, and necrotic cells via flow cytometry.
  • Analysis of gene expression changes using RNA microarrays.

Main Results:

  • Resveratrol application significantly induced apoptotic cell death in HT1080 cells.
  • Cell proliferation was markedly reduced following resveratrol treatment.
  • Microarray analysis revealed alterations in the expression of apoptosis-associated genes.

Conclusions:

  • This in vitro study confirms the anticancer activity of resveratrol against human fibrosarcoma.
  • The findings provide a basis for in vivo studies evaluating resveratrol's therapeutic potential for fibrosarcoma.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.4K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
72